Latest filing published 07 Oct 2025 for scPharmaceuticals Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Leonard d. Schaeffer discloses dealings in scPharmaceuticals Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 26 August 2024 to 7 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 7 October 2025 came the latest disclosure, a transaction in scPharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations